Novel iron-containing phosphate binders and anemia treatment in CKD: oral iron intake revisited.

Nakanishi, Takeshi; Hasuike, Yukiko; Nanami, Masayoshi; Yahiro, Mana; Kuragano, Takahiro

Nakanishi, Takeshi; Hasuike, Yukiko; Nanami, Masayoshi; Yahiro, Mana; Kuragano, Takahiro.

Afiliação

Nakanishi T; Department of Internal Medicine, Division of Kidney and Dialysis, Hyogo College of Medicine, Nishinomiya, Japan.
Hasuike Y; Department of Internal Medicine, Division of Kidney and Dialysis, Hyogo College of Medicine, Nishinomiya, Japan.
Nanami M; Department of Internal Medicine, Division of Kidney and Dialysis, Hyogo College of Medicine, Nishinomiya, Japan.
Yahiro M; Department of Internal Medicine, Division of Kidney and Dialysis, Hyogo College of Medicine, Nishinomiya, Japan.
Kuragano T; Department of Internal Medicine, Division of Kidney and Dialysis, Hyogo College of Medicine, Nishinomiya, Japan.

Nephrol Dial Transplant ; 31(10): 1588-94, 2016 10.

Article em En | MEDLINE | ID: mdl-26142396

Assuntos

Anemia/tratamento farmacológico; Compostos Férricos/administração & dosagem; Hiperfosfatemia/tratamento farmacológico; Insuficiência Renal Crônica/tratamento farmacológico; Administração Oral; Anemia/sangue; Animais; Compostos Férricos/farmacocinética; Humanos; Hiperfosfatemia/sangue; Fosfatos/sangue; Insuficiência Renal Crônica/sangue

Palavras-chave

anemia; hepcidin; inflammation; iron; phosphate binder

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Férricos / Insuficiência Renal Crônica / Hiperfosfatemia / Anemia Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google